One major step toward health equity, which includes increasing insurance access and lowering cost barriers, is through education. Below is diaTribe's series on access, covering a variety of topics ...

Fully closed loop systems take automated insulin delivery a step further by skipping meal announcements. People with diabetes in the open source community are using fully closed loop systems, and ...

Adam Brown’s acclaimed diaTribe column, Adam’s Corner, has brought life-transforming diabetes tips to over 1 million people since 2013. In this highly actionable guide, he shares the food, mindset, ...

Discover ways to reduce your risk for cardiovascular complications like heart attack and stroke. Read more about ways to prevent or minimize gastrointestinal issues related to diabetes such as ...

Type 1 diabetes occurs when the body's immune system destroys cells in the pancreas that produce insulin, which is needed to convert sugar (glucose) from food into energy for most of the body’s cells.

Hypoglycemia refers to low blood sugar levels. A blood sugar level below 70 mg/dl (3.9 mmol/L) is typically considered hypoglycemia, and you will likely experience symptoms when your blood sugar dips ...

Insulin is a hormone made by the pancreas that faciliates glucose uptake into the body's cells. Most insulin is taken by injection or through a pump. SGLT-2 inhibitors are a type of oral medication ...

Type 2 diabetes occurs when the body has trouble processing glucose (or sugar) from the bloodstream to use for energy. It means the body isn’t using insulin effectively, and it’s characterized by high ...

Learn how clinical trials work, the experience of participating, and more.

SGLT-2 inhibitors are a type of oral medication that people with type 2 diabetes can use to lower blood sugar levels. How do SGLT-2 inhibitors work to lower blood sugar As our kidneys filter our blood ...

Join actively recruiting type 1 diabetes clinical trials that you may be able to participate in now.

With the advancements in Continuous Glucose Monitoring and Time in Range, we find ourselves at a transformational moment in the care of people with diabetes. Researchers, engineers, and clinicians ...